Stocks
Bristol-Myers (BMY) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 20 118 | 19 221 | 19 366 | 3 168 | 15 230 | 13 776 | ||
| Changes by years, y/y, % | +308% | -4% | +1% | -84% | +381% | +25.3% | |||
Bristol-Myers. EBITDA US GAAP, bln rub
Bristol-Myers. EBITDA US GAAP, changes, %
Bristol-Myers. EBITDA US GAAP, sum by quarters, bln rub
Bristol-Myers (BMY) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EBITDA, bln rub | ? | 3 287 | 4 605 | 2 879 | 4 245 | 4 940 | 13 776 | |
| Changes by years, y/y, % | -25% | -4% | +13% | -5% | +50% | |||
| Changes by quarters, q/q, % | -27% | +40% | -37% | +47% | +16% | |||
